Key result
Overall mortality in patients with a slow heart rate following myocardial infarction remains high despite the use of drugs such as atropine, steroids, and isoprenaline.
Why the study?
Does pharmacological treatment of slow heart rates improve mortality in patients following acute myocardial infarction?
Does pharmacological treatment of slow heart rates improve mortality in patients following acute myocardial infarction?
Slow heart rates following acute myocardial infarction are associated with high mortality despite available pharmacological treatments.
No takes yet. Share an insight, caveat, or question.
Mortality remains high despite atropine, steroids, and isoprenaline for post-MI bradycardia; challenges drug efficacy and supports trials of pacing or alternatives.
Harris et al. (1966) studied Slow heart rates following acute myocardial infarction. Overall mortality in patients with a slow heart rate following myocardial infarction remains high despite the use of drugs such as atropine, steroids, and isoprenaline.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: